SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-16-032028
Filing Date
2016-05-16
Accepted
2016-05-16 16:11:04
Documents
4
Period of Report
2016-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20160516_8k.htm 8-K 24383
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 18661
3 diffu2.jpg GRAPHIC 4784
4 diffu.jpg GRAPHIC 5629
  Complete submission text file 0001437749-16-032028.txt   59054
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24477 | Film No.: 161653851
SIC: 2834 Pharmaceutical Preparations